Vergoeding 2018-2022 voor ATC-subgroep R03BB : Parasympathicolytica
- Raming voor de totale Zvw-populatie
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| R03BB01 Ipratropium (Atrovent ®) | 3.224.300 | 3.067.900 | 2.920.200 | 2.642.800 | 2.526.400 |
| R03BB04 Tiotropium (Spiriva ®) | 64.080.400 | 59.435.700 | 55.157.900 | 39.116.300 | 33.616.000 |
| R03BB05 Aclidiniumbromide (Eklira ®) | 1.375.100 | 1.253.500 | 1.190.800 | 1.099.600 | 1.055.600 |
| R03BB06 Glycopyrroniumbromide (Seebri breezhaler ®) | 2.101.800 | 1.821.800 | 1.573.600 | 1.219.700 | 1.119.700 |
| R03BB07 Umeclidiniumbromide (Incruse ellipta ®) | 649.030 | 689.650 | 773.830 | 1.963.200 | 1.991.000 |
| Totaal | 71.430.630 | 66.268.550 | 61.616.330 | 46.041.600 | 40.308.700 |